Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Rosalynn M. Nazarian, MD"'
Autor:
Wen Wen, MD, MMSc, Scott Krinsky, BA, Daniela Kroshinsky, MD, Olivia Durant, Jeffrey He, Rituvanthikaa Seethapathy, MD, Shelsea Annette St. Hillien, BA, Beza Mengesha, MD, Rajeev Malhotra, MD, Vipul Chitalia, MD, PhD, Rosalynn M. Nazarian, MD, Jeremy Goverman, MD, Karen S. Lyons, PhD, FGSA, Sagar U. Nigwekar, MD, MMSc
Publikováno v:
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 7, Iss 1, Pp 81-92 (2023)
Objective: To describe the pain intensity among hospitalized patients with calciphylaxis, elucidate the factors associated with pain improvement, and examine the link between pain improvement and clinical outcomes. Patients and Methods: Patients were
Externí odkaz:
https://doaj.org/article/6d2cdd371aad4bb2a44cb186d98f9d8d
Publikováno v:
JAAD Case Reports, Vol 9, Iss , Pp 54-56 (2021)
Externí odkaz:
https://doaj.org/article/cbe88342996542f883f65fb423d19b4e
Autor:
Diana W. Bartenstein, BA, Taylor M. Coe, MD, Samantha C. Gordon, MD, Alison M. Friedmann, MD, Maryanne M. Senna, MD, Cassandra M. Kelleher, MD, Cristina R. Antonescu, MD, Rosalynn M. Nazarian, MD, Elena B. Hawryluk, MD, PhD
Publikováno v:
JAAD Case Reports, Vol 4, Iss 2, Pp 185-188 (2018)
A 14-month-old boy presented with a slow-growing, asymptomatic back plaque, which was biopsied and found to have S100 positivity, sparse CD34 staining, and no significant mitotic activity, nuclear pleomorphism, or necrosis; genetic workup found LMNA-
Externí odkaz:
https://doaj.org/article/7b752e50933d4927a2892e2db0f75193
Publikováno v:
JAAD Case Reports, Vol 3, Iss 2, Pp 151-154 (2017)
Externí odkaz:
https://doaj.org/article/9879e3cc75a54e4685390d0a8cf1092b
Autor:
Samantha M. Guhan, BA, Janelle S. Nassim, MD, Melissa Krystel-Whittemore, MD, Rosalynn M. Nazarian, MD, Bonnie T. Mackool, MD
Publikováno v:
International Journal of Women's Dermatology, Vol 6, Iss 4, Pp 336-337 (2020)
Externí odkaz:
https://doaj.org/article/e27cc38c0dfb4d1aa780b550662e2399
Autor:
Galit H. Frydman DVM, ScD, Edward W. Boyer MD, PhD, Rosalynn M. Nazarian MD, Elizabeth M. Van Cott MD, Gregory Piazza MD, MS
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 26 (2020)
Severe acute respiratory syndrome coronavirus 2 infection (COVID-19) is known to induce severe inflammation and activation of the coagulation system, resulting in a prothrombotic state. Although inflammatory conditions and organ-specific diseases hav
Externí odkaz:
https://doaj.org/article/0ff763bd05e147bc8e824ec100b36403